Felipe Gazos Lopes
About Felipe Gazos Lopes
Felipe Gazos Lopes serves as the Associate Director and Senior Scientist at Tessera Therapeutics, where he has worked since 2020. He possesses over a decade of experience in small molecule analysis and specializes in chromatography and mass spectrometry.
Work at Tessera Therapeutics
Felipe Gazos Lopes has been with Tessera Therapeutics since 2020, initially serving as a Senior Scientist. In 2022, he advanced to the role of Associate Director. His work is based in Somerville, Massachusetts, where he coordinates collaborative projects that involve multiple personnel to generate results. His expertise contributes to the company's focus on innovative therapeutic solutions.
Previous Experience at Dicerna Pharmaceuticals
Before joining Tessera Therapeutics, Felipe worked at Dicerna Pharmaceuticals, Inc. as a Scientist from 2019 to 2020. He held the position of Scientist II for a brief period in 2020. His tenure at Dicerna involved contributing to research initiatives in the biotechnology sector, enhancing his experience in small molecule analysis.
Background in Academia
Felipe Gazos Lopes has a strong academic background. He earned a Doctor of Philosophy (PhD) in Pathobiology from The University of Texas at El Paso, where he studied from 2009 to 2015. He also completed a Master's degree in Biological Chemistry and a Bachelor's degree in General Biology, both from Universidade Federal do Rio de Janeiro. His academic journey laid the foundation for his expertise in analytical techniques.
Postdoctoral Fellowship at Harvard T.H. Chan School of Public Health
Felipe served as a Postdoctoral Fellow at Harvard T.H. Chan School of Public Health from 2015 to 2018. This role allowed him to further develop his research skills and contribute to public health initiatives in the Greater Boston Area. His experience during this period enhanced his analytical capabilities and understanding of complex biological systems.
Specialization in Analytical Techniques
Felipe specializes in chromatography and mass spectrometry, focusing on both qualitative and quantitative analysis. He has over a decade of experience in small molecule analysis and is recognized for developing and streamlining analytical platforms for metabolites. His technical skills are integral to his roles in both academic and industry settings.